| (210) | Number of the EPO application | 15820351 |
| (220) | Filing date of the EPO application | 2015.12.03 |
| (80) | EPO patent specification publication (B) | EPB nr. 21/2021, 2021.05.26 |
| (110) | EPO patent number | 3226843 |
| (11) | Number of the document | MD 3226843 T2 |
| (21) | Number of the application | e 2017 0154 |
| (71) | Name(s) of applicant(s), code of the country | Aragon Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | VERRECK Geert, BE; |
| (73) | Name(s) of owner(s), code of the country | Aragon Pharmaceuticals, Inc., US; |
| (54) | Title of the invention | Anticancer compositions |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/20 (2006.01.01); A61P 35/00 (2006.01.01); A61P 35/04 (2006.01.01); A61K 9/14 (2006.01.01); A61K 31/4439 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2017.12.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.10.31 |
| (30) | Priority | 14196605, 2014.12.05, EP |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2015/063671, 2015.12.03 |
| (87) | International publication | WO 2016/090105, 2016.06.09 |